Clinicians' attitudes to clinical trials of cancer therapy

European Journal of Cancer

Volumn 33, Issue 13, 1997, Pages 2221-2229

  Fallowfield, L ^a   Ratcliffe, D ^a   Souhami, R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical trials; Oncologists' attitudes

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED STUDY; EXPERIENCE; HEALTH CARE SYSTEM; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS; COMMUNICATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; PHYSICIAN-PATIENT RELATIONS; RESEARCH; UNITED STATES;

EID: 0031409279     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00253-0     Document Type: Article

References (18)

1. Ward LC, Fielding JWL, Dunn JA, Kelly KA. The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. Br J Cancer 1992, 66, 943-950.
2. Smyth JF, Mossman J, Hall R, et al. Conducting clinical research in the new NHS. Br Med J 1994, 309, 457-461.
3. Collins R, Doll R, Peto R. Ethics of clinical trials. In Williams CJ, ed. Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems. Chichester, Wiley, 1992, 49-65.
4. Wingerson D, Sullivan M, Dager S, et al. Personality traits and early discontinuation from clinical trials in anxious patients. J Clin Psychopharmacol 1993, 13, 194-197.
5. Taylor KM, Feldstein ML, Skeel RT, et al. Fundamental dilemmas of the randomised clinical trial process: Results of a survey of the 1, 737 ECOG investigators. J Clin Oncol 1994, 12, 1796-1805.
6. Taylor KM, Keiner M. Interpreting physician participation in randomised clinical trials: The Physician Orientation Profile, J Health Soc Behav 1987, 28, 389-400.
7. Raphael A. How doctors' secret trials abused me. 1988, Observer, 9th October.
8. Sutherland HJ, Lockwood GA, Till J. Are we getting informed consent from patients with cancer? J Roy Soc Med 1990, 83, 439-443.
9. Kesssel AS. On failing to understand informed consent. Br J Hasp Med 1994, 52, 235-238.
10. Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS. Cancer patients' perceptions of their disease and its treatment. Br J Cancer 1988, 58, 355-358.
11. Sheldon JM, Felting JH, Siminoff LA. Offering the option of randomised clinical trials to cancer patients who overestimate their prognoses with standard therapies. Cancer Invest 1993, 11, 57-62.
12. Fallowfield LJ. Communication skills of oncologists. Trends Exp Clin Med 1995, 5, 99-103.
13. Gotay CC. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med 1991, 33, 569-577.
14. Segelov E, Tattersall MHN, Coates AS. Redressing the balance- the ethics of not entering an eligible patient on a randomised clinical trial. Ann Oncol 1992, 3, 103-105.
15. Tabachnik BG, Fidell LS. Using Multivariate Statistics, 2nd edn. New York, Harper Collins, 1989, 539.
16. Begg CB, Engstrom PF. Eligibility and extrapolation in cancer clinical trials. J Clin Oncol 1986, 4, 972-974.
17. Baum M. New approach for recruitment into randomised controlled trials. Lancet 1993, 341, 812-813.
18. Stiller C. Survival of patients in clinical trials and at specialist centres. In Williams CJ, ed. Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems. Chichester, Wiley, 1992, 119-136.